Hepatitis Vaccination in HIV Infection: Role of Adjuvant Interleukin-2

Authors
Category Primary study
Registry of TrialsClinicalTrials.gov
Year 2007
The response to vaccination for hepatitis is reduced in patients with HIV infection. The hypothesis of the study is that adjuvant interleukin-2 administered subcutaneously at the time of vaccination improves the response rate.
Epistemonikos ID: 5595f7534b5a96a56331e3aa40c26812b239855e
First added on: Nov 24, 2021